CenTrial Logo

Is Cetirizine Helpful in Reducing Hair Loss?


Clinical trial finds cetirizine effecting is slowing hair loss

A recent clinical trial has explored the use of a new drug called topical cetirizine in the treatment of patients suffering from hair loss or alopecia.

Hair loss is a common problem that can affect both men and women, and it can have a significant impact on a person's quality of life, confidence, and self-esteem. Androgenetic alopecia, also known as male or female pattern baldness, is the most common type of hair loss, affecting millions of people worldwide. Hair is lost in a well-defined pattern, beginning above both temples. Over time, the hairline recedes to form a characteristic "M" shape.

Androgenetic alopecia is a genetic condition that occurs due to the excessive effect of hormones called androgens which are produced in the body to regulate sexual development.

There are many treatments available for this type of hair loss such as topical minoxidil, platelet-rich plasma (PRP), various oral drugs and supplements, and hair transplant surgery. All of these treatments have their side effects and doctors have been continuously looking for newer drugs with lower negative effects.

One of these drugs is topical cetirizine which can be applied directly to the skin. It is an antihistamine that is commonly used to treat allergies, but it has also been found to have anti-inflammatory properties that may be useful for treating hair loss. Although this drug has been in use for many years, strong clinical evidence justifying its use in preventing hair loss has been lacking.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
Recently, a systematic review of three clinical trials was conducted to explore the potential of topical cetirizine for treating androgenetic alopecia. The study was published in the Journal of Cosmetics Dermatology and was aimed at investigating whether cetirizine could stimulate hair growth and prevent further hair loss in alopecia patients.

The clinical study included a comprehensive review of previously completed clinical trials on the use of topical cetirizine for hair loss.

The results of the clinical study showed that topical cetirizine improved hair growth and prevented hair loss in patients with alopecia. It also demonstrated that cetirizine improved hair diameter and has a longer-lasting effect compared to topical minoxidil. Cetirizine was also safe and had a very low risk of side effects.

In conclusion, the clinical study suggests that topical cetirizine may be a safe and effective treatment option for reducing hair loss and stimulating hair growth in individuals with androgenetic alopecia. Be sure to seek the advice of a qualified doctor before starting any medication for hair loss.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.